26 results on '"Yu, Z."'
Search Results
2. P2.05-10 The Power for PD-L1 Expression to Predict Immune Checkpoint Blockade Outcomes is Determined by Tumor Transcriptome
3. EP11.02-03 First Line Sintilimab plus Anlotinib vs Platinum-based Chemotherapy in Metastatic NSCLC (SUNRISE): Updated Efficacy and Safety Analysis
4. EP05.01-16 Re Evaluation of a Larger Sample: Anatomical Variation Analysis of Left Upper Pulmonary Based on 3Dreconstruction of Chest CT
5. EP11.03-41 Successful Treatment with Pembrolizumab Alone for SMARCA4-deficient Lung Sarcomatoid with a High-TMB and PD-L1(+) A Case Report
6. EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
7. EP08.02-057 Mechanism of Resistance to Second-Line Aumolertinib and Therapeutic Regime after Resistance
8. MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
9. P53.03 The Characteristics of FGFR Genetic Aberrations in Chinese Lung Cancer Patients
10. P57.04 Mutations of DNA Damage Repair Genes in Lung Adenocarcinoma and Their Association with Actionable Alterations
11. 37P Pralsetinib in acquired RET fusion-positive advanced non-small cell lung cancer patients after resistance to EGFR/ALK-TKI: A China multi-center, real-world data (RWD) analysis
12. OA02.03 The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
13. MA13.11 A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
14. EP1.18-20 Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Initial Short-Term Results from a Single Institute in Northeast China
15. P1.17-20 Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Lung Cancer
16. EP1.14-13 EGFR Mutation in Lung Adenocarcinoma: Real World Study from a Single Institute
17. P1.03-47 KEAP1 Mutations in East Asian Patients with NSCLC: An Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis
18. OA09.03 STK11/LKB1 Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy in NSCLC: Results From Three Randomized Trials.
19. P120 How to Become Exsomes As Messengers and Sentinels to Influence Lung Cancer Growing?
20. P006 Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Small Lung Nodule
21. P017 Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer
22. P024 Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Experience of a Single Institute
23. P3.01-113 A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)
24. JCSE01.18 A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)
25. P1.15-17 Risk Factors of Local Recurrence in EGFR-Mutant Stage III-pN2 Adenocarcinoma After Complete Resection: A Multi-Center Real-World Cohort Study
26. P3.01-087 Impact Factor Analysis for Efficacy and Prognosis of Anlotinib in NSCLC as Third-Line Treatment: Data from Trial ALTER 0303
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.